Chinese Traditional and Herbal Drugs
|
2025, 56(19): 6934-6946
Preparation of grapefruit exosome-like vesicle-loaded salidroside biomimetic nanoparticles and in vitro evaluation of anti-cerebral ischemic injury
Full
HU Pingting, SHI Yabo, ZHU Anran, LI Nengjin, LI Jiale, ZHANG Wen, DI Liuqing, WANG Ruoning
Affiliations
doi: 10.7501/j.issn.0253-2670.2025.19.006
Outline
Objective To prepare inexpensive, safe and non-toxic grapefruit exosome-like vesicles (GEVs) loaded with salidroside (Sal) bionanoparticles (GEVs/Sal) with strong blood-brain barrier (BBB) penetration capacity, and to investigate their anti-ischemic injury effects in vitro. Methods GEVs were extracted by differential centrifugation and ultrafiltration, and their characteristic membrane proteins were detected by flow cytometry. GEVs/Sal were prepared by ultrasonic fragmentation, characterized by nanoparticle tracking analysis for particle size, and HPLC for drug loading and encapsulation rates; Transwell method was used to investigate the BBB penetration and protective ability; MTT method, immunofluorescence staining and qRT-PCR were used to investigate the protective effect of GEVs/Sal on damaged PC12 cells. Results GEVs expressed CD81 and CD9 characteristic membrane proteins, indicating that the vesicles were successfully extracted, and HPLC showed that GEVs contained the characteristic component naringin (NAR), which may play a synergistic role with the traditional Chinese medicine; The optimal preparation prescription ratio for GEVs/Sal was mGEVs∶mSal= 10∶1, drug loading, encapsulation efficiency, particle size and zeta potential were (8.07 ± 0.23)%, (91.08 ± 2.65)%, (173.9 ± 3.8) nm, (−11.49 ± 0.48) mV, respectively; MTT assay result showed that concentration within 100 μmol/L of GEVs/Sal had no significant cytotoxicity on PC12 cells, and 50 μmol/L of GEVs/Sal significantly improved the viability of PC12 cells induced by oxygen glucose deprivation/reoxygenation (OGD/R); It was further demonstrated that PC12 cells mediated the internalization of GEVs/DiO through clathrin and lipid raft interaction; It was demonstrated by constructing an in vitro BBB model that GEVs/Sal could effectively cross the BBB, and it was further confirmed that hCMEC/D3 cells mediated the internalization of GEVs/DiO through clathrin and macropinocytosis interaction; The results of FITC-Dextran leakage assay showed that GEVs/Sal reduced the permeability of the BBB after OGD/R injury; Calcein AM/PI staining and mitochondrial function investigation revealed that GEVs/Sal could inhibit cell apoptosis, improve mitochondrial membrane potential and restore cellular energy metabolism processes. qRT-PCR analysis showed that GEVs/Sal increased the gene expression of B cell lymphoma-2 (Bcl-2), decreased the gene expressions of Bcl-2 associated X protein (Bax) and cysteine containing cysteine aspartate-3 (Caspase-3), thereby exerting an inhibitory effect on cell apoptosis. In addition, immunofluorescence staining showed that GEVs/Sal intervention could induce polarization of BV2 cells towards M2 type and mediate anti-inflammatory effects. Conclusion GEVs/Sal, a highly efficient drug-carrying and stable biomimetic nanomedicine delivery platform, has been successfully prepared and has been demonstrated to have good neuroprotective effects against OGD/R-induced neuronal damage, suggesting a new therapeutic strategy for ischemic stroke.
salidroside
/
grapefruit exosome-like vesicles
/
ischemic stroke
/
biomimetic nanoparticles
/
reperfusion injury
胡娉婷, 史亚博, 朱安然, 李能进, 李佳乐, 张雯, 狄留庆, 王若宁.
葡萄柚囊泡载红景天苷仿生纳米粒的制备及体外抗脑缺血损伤评价.
中草药,
2025
, 56
(19)
: 6934
-6946
.
DOI: 10.7501/j.issn.0253-2670.2025.19.006
HU Pingting, SHI Yabo, ZHU Anran, LI Nengjin, LI Jiale, ZHANG Wen, DI Liuqing, WANG Ruoning.
Preparation of grapefruit exosome-like vesicle-loaded salidroside biomimetic nanoparticles and in vitro evaluation of anti-cerebral ischemic injury[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(19)
: 6934
-6946
.
DOI: 10.7501/j.issn.0253-2670.2025.19.006
Year 2025 volume 56 Issue 19
57
10
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.19.006
- Receive Date:2025-04-12
- Online Date:2026-11-13